Effects of ligand activation of PPAR-gamma in human prostate cancer – (10-26-00)

Effects of ligand activation of PPAR-gamma in human prostate cancer

I’ve said many times before that I truly believe that most chronic diseases in humans stems from relatively few biochemical defects. This is yet more evidence of this. The new class of diabetic drugs have been shown to inhibit prostate cancer. Just remember that conjugated linoleic acid (CLA) is also a PPAR-gamma ligand without the known hepatotoxicity.

PNAS — Abstracts: Mueller et al. 97 (20): 10990

Read entire article here

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email: